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Objective: The purpose of this study was to answer two questions: (1) Does 
a mixed amino acid infusion enhance systemic and renal perfusion in the 
early postoperative period after heart operations? (2) Does the addition of 
insulin (glucose-insulin-potassium solution) provide additional effects to 
those of an amino acid infusion? Methods: Thirty-three male patients 
undergoing coronary artery bypass grafting (mean age 65.9 -- 1.2 years) 
were included in a prospective, controlled, randomized study. Eleven 
patients (AA group) received infusion of mixed amino acids (11.4 gm), 11 
patients (AA + GIK group) received infusion of mixed amino acids (11.4 
gm) and insulin solution (225 IU insulin, glucose with glucose clamp 
technique, and potassium), and 11 patients served as control subjects. 
Results: Amino acid infusion alone had no effect on systemic vascular 
resistance or cardiac index but increased renal blood flow 51% --. 11% (from 
114 -+ 13 to 172 - 24 ml • min -1 • m -2 in one kidney, p < 0.05 vs the control 
group). Insulin solution in addition to amino acid infusion reduced 
systemic vascular resistance 24% -- 3% (from 1280 - 85 to 960 -+ 57 
dyn • sec.  cm -5, p < 0.05 vs the control and AA groups) and increased 
cardiac index 13% -+ 3% (from 2.3 - 0.2 to 2.6 + 0.2 L .  min -1. m -2, p < 
0.05 vs the control and AA groups). Insulin had no significant additive effect 
on renal blood flow. Conclusions: Our data imply that (1) infusion of mixed 
amino acids enhances renal blood flow after cardiac operations but has no 
effect on systemic perfusion and (2) the addition of insulin solution 
improves systemic perfusion. The combined treatment may potentially 
reduce the risk of renal hypoperfusion injury in the postoperative period 
after coronary artery bypass grafting. (J Thorac Cardiovasc Surg 1997;113: 
594-602) 
R enal dysfunction is common in the postoperative period after cardiac operations. When the renal 
dysfunction is severe enough to necessitate dialysis, 
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the prognosis is dismal with a mortality rate close to 
40%. 1 In the majority of cases, renal dysfunction is 
caused by renal hypoperfusion with resultant isch- 
emic injury. This may occur before, during, or, 
probably most important, after the operation. The 
primary event is most commonly low output heart 
failure? The kidneys may be at particular isk during 
systemic hypoperfusion i asmuch as surgical trauma 
per se induces redistribution of systemic blood flow 
with a smaller proportion of cardiac output perfus- 
ing the kidneys. 3
At most centers the treatment of postoperative 
low output syndrome is based on adrenergic sup- 
port. One drawback of this therapeutic approach is 
that high doses of most inotropic agents tend to 
cause vasoconstriction a d may thus aggravate renal 
ischemic injury. Alternative approaches to treat 
myocardial dysfunction and heart failure are the use 
of insulin (in combination with glucose and potas- 
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slum, that is, glucose-insulin-potassium [GIK] solu- 
tion), 4' s infusion of amino acids such as glutamate, 6 
or use of both these methods. These agents may be 
beneficial also from the aspect of renal hypoperfu- 
sion, because both insulin and various amino acids 
can decrease renal vascular resistance (RVR)  and 
enhance renal blood flow (RBF) during nonsurgical 
conditions.7, 8 The effects of these agents on renal 
perfusion, if any, in conjunction with cardiac oper- 
ations, are unknown. 
The purpose of this study was to answer two 
questions: (1) Does a mixed amino acid infusion 
enhance systemic and renal perfusion in the early 
postoperative period after heart operations? and (2) 
Does the addition of insulin (G IK  solution) provide 
additional effects to those of an amino acid infu- 
sion? 
Patients and methods 
Patients. Patients included in the study met the follow- 
ing inclusion criteria: male gender, age 40 to 80 years, two- 
or three-vessel coronary disease with stable angina and 
appropriate condition for coronary operations, left ven- 
tricular ejection fraction greater than 40%, no other 
significant disorders, and serum creatinine level less than 
15 mg/L. Exclusion criteria were perioperative myocardial 
infarction, postoperative low output heart failure, and the 
use of inotropic, vasoactive, or diuretic agents. Thirty-four 
patients were originally included in the study. One of 
these was excluded after the second measurement period 
(before treatment was initiated) because of electrocardio- 
graphic signs of perioperative myocardial infarction. 
Characteristics of the remaining 33 patients are listed in 
Table I. The study protocol was approved by the Research 
Ethics Committee of the Medical Faculty, University of 
G6teborg. Informed consent was given by all patients. 
Clinical management. The patients were given pre- 
medication consisting of flunitrazepam and morphine/ 
scopolamine. Anesthesia was induced with thiopental, 3 to 
5 mg/kg, followed by pancuronium, 0.1 mg/kg. Fentanyl 
was given in incremental doses up to a total amount of 8 
to 10 tzg/kg before sternotomy. Normal parameters were 
used for ventilation of the lungs with oxygen in air 
(fraction of inspired oxygen 0.4 to 0.5), and enflurane was 
used as an inhalational agent both before and after 
cardiopulmonary bypass. Midazolam was given during 
cardiopulmonary b pass. 
The operations were done with a standard nonpulsatile 
cardiopulmonary b pass technique, with moderate hypo- 
thermia (nasal temperature 30 ° C) and hemodilution (he- 
matocrit level 20% to 30%). Cardioprotection was 
achieved with St. Thomas' Hospital crystalloid cardiople- 
gic solution. Weaning from bypass was done after the 
patient was rewarmed to a rectal temperature of at least 
36 ° C. 
Study protocol. Before the operation, a femoral artery 
catheter and a Swan-Ganz pulmonary artery catheter 
(Baxter Healthcare Corp., Edwards Division, Santa Ana, 
Table I. Patient characteristics 
Group 
AA AA + GIK Control 
(n = 11) (n = 11) (n = 11) 
Age (yr) 
Body surface area (m 2) 
Body weight (kg) 84 ± 5.6 
Preoperative l ft ventricular 61 ± 5 
ejection fraction (%) 
Coronary disease 9/2 
(2wessel/3-vessel) 
Serum creatinine l vel 
(my/L) 
Preoperative 
Peak postoperative 
At hospital discharge 
Aortic crossclamping (min) 
Extracorporeal circulation 
(min) 
Peripheral anastomoses 
(No.) 
Days in hospital 
63.3±2.2 66.6± 1.8 64.2±2.7 
1.99 +- 0.07 1.99 -+ 0.04 1.99 ± 0.06 
81 ± 3.9 85 ± 4.1 
63 ± 2 64 ± 3 
8/3 9/2 
11.4±0.5 11.5±0.5 11.6±0.5 
11.2±0.6 12.2±1.0 12.0±0.7 
10.3-+0.5 10.9-+0.7 10.0-+0.5 
51±5 46±4 53±6 
90 ± 6 86 -+ 5 88 +- 6 
3.4±0.2 3.3±0.1 3.4±0.2 
7.0-+0.4 7.1-+0.4 7.4-+0.4 
Values given as mean plus or minus the standard error of the mean. There 
was no significant difference among the groups. 
Calif.) were inserted for continuous monitoring of sys- 
temic and pulmonary arterial pressures, for measuring 
cardiac output, and for blood sampling. A thermodilution 
catheter (Webster Laboratories, Baldwin Park, Calif.) was 
inserted under fluoroscopic guidance, with the distal 
mixing thermistor placed in a central position in the left 
renal vein. The position of the catheter was checked after 
the operation. 
Hemodynamic measurements were taken at three pre- 
set times: before the operation, immediately after the 
operation (in the operating room after skin closure, with 
satisfactory clinical hemodynamic variables, that is, mean 
arterial pressure [MAP] >60 mm Hg, urinary output >2 
ml/kg of body weight per hour, and mixed venous oxygen 
saturation >60%), and after 30 minutes of infusion 
(which continued while the measurements were taken). 
After the first postoperative measurements were taken 
the patients were randomized to one of three groups. The 
AA group received an infusion of mixed amino acids 
(Vamin 18 gm nitrogen per liter, Pharmacia, Stockholm, 
Sweden, 200 ml/hr, composition given in Table II). The 
AA + GIK group received mixed amino acids and GIK 
solution (Vamin 18 gm nitrogen per liter, 200 ml/hr; 
Actrapid insulin, Novo Nordisk, Bagsvaerd, Denmark, 100 
units as a bolus dose followed by 250 IU/hr; glucose 30%, 
75 ml/hr initially and then adjusted according to blood 
glucose measurements; and potassium 10 mmol/hr). The 
third group served as control subjects. 
Hemodynamic measurements. MAP and central ve- 
nous pressure were measured continuously. Cardiac out- 
put was determined by the thermodilution technique. 
Pulmonary capillary wedge pressure (PCWP) was mea- 
sured immediately before each cardiac output measure- 
ment. RBF was determined by the retrograde thermodi- 
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Table II. Content of the mixed amino acid solution 
Grams per 1000 ml 
Alanine 16.0 
Arginine 11.3 
Aspartate 3.4 
Cysteine 0.56 
Glycine 7.9 
Glutamate 5.6 
Histidine 6.8 
Isoleucine 5.6 
Leucine 7.9 
Lysine 9.0 
Methionine 5.6 
Phenylalanine 7.9 
Proline 6.8 
Serine 4.5 
Threonine 5.6 
Tryptophan 1.9 
Tyrosine 0.23 
Valine 7.3 
lution technique originally described by Hornych, Brod, 
and Slechta sa and modified by Tidgren and Hjemdahl. 9 
Systemic vascular esistance (SVR) was calculated with 
the formula SVR (dyn.sec .cm 5) = 80 × (MAP - 
CVP)/CO, where CVP is central venous pressure and CO 
is cardiac output. Left ventricular stroke work index 
(LVSWI) was calculated according to the formula LVSWI 
(gm. m)/m2/beat) = 13.6 × (CI/HR) × (MAP-  PCWP), 
where CI is the cardiac index and HR is the heart rate. 
RVR was calculated according to the formula RVR (ram 
Hg. I2 1- min -1) - (MAP - CVP)/RBF, where central 
venous pressure (CVP) was assumed to be representative 
also for renal venous pressure. Renal fraction of blood 
flow (RF) was calculated with the formula RF (%) = 2 × 
RBF/CO, where CO is cardiac output and equal flow in 
both kidneys was assumed. All flow values were related to 
body surface area. 
Arterial concentrations of insulin and amino acids. 
Insulin and amino acid concentrations in arterial plasma 
were measured after 30 minutes of infusion. The concen- 
trations of amino acids were determined by ion exchange 
chromatography with use of an automated amino acid 
analyzer (Alpha Plus, LKG Products, Bromma, Sweden) 
using DC-6 ion exchange resin (Durrum, Calif.) and 
lithium citrate buffers. Orthophtaldialdehyde wasused for 
post-column derivation and fluorescent detection (Shi- 
matsu RF-535) at an excitation wavelength of 350 nm and 
an emission wavelength of 420 nm. 
Insulin level was assessed by a radioimmunoassay 
method (Insulin RIA-100, Pharmacia, Uppsala, Sweden). 
Statistical analysis. The patients were randomized to 
one of the three study regimens by a computerized 
procedure of sequential allocation 1° including the pa- 
tient's age, weight, preoperative s rum creatinine concen- 
tration, bypass time, aortic clamp time, postoperative CI, 
postoperative heart rate, and postoperative PCWP. To 
establish whether the randomization had provided groups 
that were comparable before treatment, intergroup com- 
parisons of the first and the second measurements ("con- 
trot periods") were done with one-way analysis of vari- 
ance. 
To evaluate ffects of amino acids and insulin, inter- 
group comparisons of intragroup changes between the 
two postoperative measurements (before and during 
treatment) were done with one-way analysis of variance. If
analysis of variance indicated statistical intergroup differ- 
ence (p < 0.05), Duncan's multiple range test was done. 
Student's t test was used to evaluate the difference in 
arterial insulin concentration between the AA group and 
the control group. In the AA + GIK group the insulin 
concentrations were 200- to 1000-fold higher than those in 
the other groups, which made the three-group variance 
analysis insufficient. The analysis was also insufficient 
concerning the arterial concentrations of amino acids, 
which were twofold to threefold higher in both treatment 
groups than in control subjects. In this comparison we 
used Student's t test to evaluate the difference between 
the AA and AA + GIK groups. 
Standard regression analysis was used to evaluate pos- 
sible hemodynamic predictors of CI and RBF. 
One-way analysis of covariance was done with group 
and PCWP changes (Table III, column 4) as predictors 
and CI as responder. 
Statistical significance was defined as p < 0.05. 
Results 
Clinical course. All  pat ients recovered normal ly 
after the operat ion and were discharged from the 
hospital within 10 days after the operat ion.  One 
pat ient in the AA + G IK  group had a transient 
elevation of the serum creatinine level up to 31.8 
mg/L, whereas serum creatinine levels in all the 
other pat ients were unchanged or had a transient 
increase within 25%. 
Pretreatment systemic and renal variables (Ta- 
ble III, columns 2 and 3). There were no significant 
differences between the groups in pret reatment  sys- 
temic and renal variables. 
Effects of treatment (Figs. 1 through 3) 
Arterial concentrations of insulin and amino acids. The 
insulin levels in arterial  serum differed among the 
three groups. The concentrat ion in the AA group 
was 54 _+ 11 mU-  L -1 (p < 0.01 vs control  subjects), 
in the AA + G IK  group 10,345 _+ 1396 mU.  L -1, 
and in the control  group 13 _+ 2 mU. I2  1 . The 
arterial  concentrat ions of amino acids are given in 
Table IV. The levels were twofold or threefold 
higher in the t reatment  groups compared  with those 
in control  subjects with no overlap. There was no 
difference between the AA and AA + G IK  groups. 
Systemic hemodynamic valuables (Table III, col- 
umn 5). The amino acid infusion alone (AA group) 
had no effects on systemic vascular resistance, CI, 
PCWP, or MAP.  In the AA + G IK  group systemic 
vascular esistance decreased 24% _+ 3% (p < 0.05 
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Table III. Hemodynamic variables before operation, immediately after operation, and after 30 minutes of 
infusion in A/I group and in AA + GIK group 
Before operation After operation During infusion ~ ANOVA (A) Duncan (A) 
SVR (dyn.sec.cm 2) p = 0 
AA 1631 _+ 122 1147 -- 67 1178 _+ 97 31 ± 90 
AA + GIK 1649 _+ 102 1280 _+ 85 960 _+ 57 -292 _+ 48 
Control 1472 ± 58 1114 _+ 96 1251 + 91 136 _+ 42 
CI (L/rain 1) p = 0.007 
AA 1.7 _+ 0.1 2.6 ± 0.1 2.5 _+ 0.2 0.0 ± 0.! 
AA + GIK 1.7 +_ 0.1 2.3 ± 0.1 2.6 _+ 0.2 0.3 _+ 0.1 
Control 1.8 + 0.1 2.5 ± 0.2 2.4 ± 0.2 -0.1 + 0.1 
MAP (mm Hg) p = 0.002 
AA 77 + 4.3 81 _+ 2.4 81 _+ 3.3 0 ± 3.7 
AA + GIK 75 -+ 2.2 80 ± 3.2 70 + 2.3 -11 ± 2.2 
Control 72 ± 2.2 77 +- 2.4 83 ± 3.0 6 ± 3.3 
CVP (ram Hg) NS 
AA 9 ± 0.8 10 ± 0.9 11 ± 0.7 0.4 _+ 0.8 
AA + GIK 8 ± 0.8 11 -+ 0.7 11 ± 0.7 0.3 ± 0.4 
Control 7 ± 0.7 10 ± 0.6 11 ± 0.9 0.9 ± 0.5 
PCWP (mm Hg) NS 
AA 11 _+ 1.2 12 _+ 0.8 14 ± 0.8 1.6 _+ 0.5 
AA + GIK 11 _+ 1.4 12 +_ 1.0 13 ± 1.2 0.3 ± 0.9 
Control 10 ± 1.2 12 _+ 0.9 13 _+ 1.2 1.1 +_ 0.9 
Heart rate (beats/rain) NS 
AA 53±2 78±3 78±4 0 .1±0.9  
AA+ GIK 58±3 75±4 78±2 3.0_+2.1 
Control 55 ± 3 77 ± 5 77 ± 4 0.6 ± 1.7 
LVSWI (gm.m/m2/beat) NS 
AA 29 _+ 1.6 31 _+ 1.0 30 _+ 2.4 -0.7 ± 2.4 
AA + GIK 25 ± 1.3 28 ± 2.5 26 ± 2.0 -2.5 +_ 1.1 
Control 29 ± 2.5 29 _+ 2.4 30 ± 2.2 0.7 +_ 2.1 
RVR (mm p = 0.015 
Hg.L 1.min 1) 
AA 527 ± 124 377 ± 57 258 ± 38 -119 _+ 39 
AA + GIK 525 _+ 93 515 ± 88 255 _+ 36 -259 _+ 70 
Control 424 ± 66 349 _+ 57 358 _+ 57 11 + 68 
RBF(ml .min  1 .m 2) p=0.013 
AA 98 ± 17 114 ± 13 172 _+ 24 58 + 15 
AA + GIK 83 ± 12 86 _+ 12 135 _+ 13 49 + 9 
Control 102 ± 18 131 ± 25 133 ± 26 -10  + 22 
RBF/CI (%) p = 0.032 
AA 11 + 1.7 9 ± 1.0 14 _+ 2.1 4.9 + 1.5 
AA + GIK 10 + 1.2 8 _+ 1.1 11 _+ 1.4 3.2 ± 1.0 
Control 11 ± 1.8 11 _+ 2.6 11 ± 2.1 -1.0 _+ 2.0 
Hb (gm.L ~) p - 0.013 
AA 132 + 3 104 _+ 3 104 ± 4 -0.5 ± 1.6 
AA + GIK 132 _+ 4 104 _+ 4 101 _+ 3 -3 .4 ± 1.1 
Control 135 -- 4 110 _+ 5 112 _+ 5 2.5 ± 1.2 
p < 0.05 vs AA and control groups 
p < 0.05 vs AA and control groups 
p < 0.05 vs AA and control groups 
p < 0.05 vs control group 
p < 0.05 vs control group 
p < 0.05 vs control group 
p < 0.05 vs control group 
p < 0.05 vs control group 
Values given as mean plus or minus the standard error of the mean. Intergroup comparisons incolumn 1 and in column 2 were done with one-way variance 
analysis (ANOVA). There were no statistical differences. The values in column 4 (A, the difference between the two postoperative m asurements, before and 
during treatment) are compared with one-way variance analysis (ANOVA) and, when p < 0.05, followed by Duncan's multiple range test. Statistical 
differences between the group changes (A) are indicated. SVR, Systemic vascular esistance; CVP, central venous pressure; NS, not significant; LVSWI, left 
ventricular stroke work index; Hb, arterial content of hemoglobin. 
vs control and AA groups), CI increased 13% _+ 3% 
(p < 0.05 vs control and AA groups), and MAP 
decreased 13% _+ 2% (p < 0.05 vs control and AA 
groups). There were no differences in left ventricu- 
lar stroke work index between the groups. There was 
no significant correlation between changes in PCWP 
and CI (r = 0.15). Analysis o f  covariance indicated 
that group had an effect on CI (F = 8.18, degree of 
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Fig. 1. Systemic vascular esistance before (black bars) and during (white bars) infusion of amino acids in the AA 
group (n = 11) and infusion of amino adds and GIK solution in the AA + GIK group (n = 11). The control group 
(n = 11) did not receive any trealnaent. Statistical evaluation of treatment is given in Table III. 
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Fig. 2. RVR before (black bars) and during (white bars) infusion of amino acids in the AA group (n = 11) 
and infusion of amino acids and GIK solution in the AA + GIK group (n = 11). The control group (n = 
11) did not receive any treatment. Statistical evaluation of treatment is given in Table III. 
f reedom = 2, p < 0.001) and that PCWP changes 
affected CI response (F = 5.04, degree of free- 
dom = 1, p = 0.03). The slopes Were equal (F = 
0.20, degree of freedom = 2, p = 0.82). 
Renal hemodynamic variables (Table III, column 
5). The amino acid infusion alone increased RBF 
58 _+ 15 ml .  min 1. m-2 (one kidney), correspond- 
ing to a 51% _+ 11% increase (p < 0.05 vs control 
subjects). RVR decreased numerically in the AA 
group, but the change did not differ significantly 
from the control values according to Duncan's mul- 
tiple range test. The addition of insulin (GIK solu- 
tion) did not increase RBF further. It increased 
49 _+ 9 ml- min -1- m -2 (one kidney), corresponding 
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Fig. 3. Renal fraction of cardiac output (RBF/CO) before (black bars) and during (white bars) infusion of 
amino acids in the AA group (n = 11) and infusion of amino acids and GIK solution in the AA + GIK 
group (n = 11). The control group (n -- 11) did not receive any treatment. Statistical evaluation of 
treatment is given in Table III. 
to a 73% _-~ 19% increase (p < 0.05 vs control 
subjects). In the AA + GIK group RVR decreased 
significantly versus the control group. However, the 
analysis indicated that there was no difference be- 
tween the AA and AA + GIK groups. The renal 
fraction (RBF/cardiac output) increased in the AA 
group from 9% + 1% to 14% _+ 2% (p < 0.05 vs 
control group). There was no significant correlation 
between changes in MAP and RBF (r = -0.23) or 
between changes in CI and RBF (r = 0.02). 
Discussion 
These data indicate that the addition of insulin 
(GIK solution) to a mixed amino acid infusion 
enhances ystemic and renal perfusion in the post- 
operative period after cardiac operations in patients 
with an uncomplicated postoperative course. The 
mixed amino acid infusion alone improved renal 
perfusion equally well, but had no effects on sys- 
temic hemodynamic variables. This suggests that the 
use of amino acids and GIK solution may provide a 
treatment for low output heart failure after cardiac 
operations, which may reduce the risk of renal 
hypoperfusion injury. However, the suggestion 
prompts follow-up studies in patients with higher 
risk conditions. 
Methodologic issues. The study design may be 
debated. The first issue is the selection of patients. We 
chose patients who we anticipated would have an 
uncomplicated postoperative course, without need for 
inotropic, vasoactive, or diuretic agents. This was done 
to facilitate the evaluation of amino acid and GIK 
treatments. It is appreciated that the selection restricts 
the validity of conclusions to this patient category. 
However, we reasoned that a pilot study of patients at 
low risk would be valuable for the design of subse- 
quent studies in patients who are more at risk for the 
development of heart and renal failure. 
Another aspect of the current protocol is the two 
alternative treatments. It could be argued that the 
effects of insulin should have been studied without 
the infusion of amino acids. Amino acids may have 
concealed insulin-induced renal vasodilation. How- 
ever, insulin alone reduces the plasma concentration 
and intracellular content of most amino acids. 11 We 
reasoned that it could be even more difficult to 
evaluate the effects of insulin per se at a reduced 
availability of amino acids, because this could have 
obviated true effects of insulin. With the present 
protocol, amino acid levels were elevated in both 
treatment groups to ascertain that the availability of 
amino acids was unrestricted. With some reserva- 
tion, it should be possible to evaluate insulin effects 
by subtracting the effects of amino acid infusion 
alone from the combined effect of insulin (GIK 
solution) and amino acid infusion. This reasoning 
may not be valid, however, if insulin and amino acid 
effects have a common mediator. 
6 0 0 Jeppsson et al. 
Table IV. Arterial concentrations of amino acids 
after 30 minutes of infusion in AA group and in 
AA + GIK group 
Concentration (Ixg/L) 
Alanine 
AA 942 _+ 97 
AA + GIK 1090 _+ 95 
Control 242 _+ 28 
Arginine 
AA 462 _+ 60 
AA + GIK 468 _+ 19 
Control 85 ± 7 
Aspartate 
AA 80 ± 11 
AA + GIK 75 ± 3 
Control 4 ± 0.4 
Citrulline 
AA 35_+7 
AA + GIK 36 _+ 4 
Control 26 ± 2 
Glutamate 
AA 383 _+ 48 
AA ± GIK 303 ± 16 
Control 80 _+ 6 
Glutamine 
AA 559 ± 46 
AA + GIK 635 ± 27 
Control 470 _+ 31 
Glycine 
AA 598 ± 63 
AA + GIK 687 -+ 20 
Control 167 + 20 
Histidine 
AA 271 ± 28 
AA+ GIK 310_+7 
Control 80 ± 5 
Isoleucine 
AA 313 ± 27 
AA + GIK 301 ± 12 
Control 63 ± 2 
Leucine 
AA 489 ± 43 
AA + GIK 473 ± 19 
Control 149 ± 6 
Methionine 
AA 169 _+ 22 
AA + GIK 176 ±4 
Control 16 ± 2 
Ornithine 
AA 108 ± 13 
AA + GIK 108 _+ 6 
Control 48 _+ 4 
Phenylalanine 
AA 236 ± 23 
AA+ GIK 251±8 
Control 52 _+ 4 
Serine 
AA 260 + 29 
AA + GIK 296 _+ 11 
Control 82 ± 11 
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Table IV. Cont'd. 
Concentration (Ixg/L) 
Taurine 
AA 83_+8 
AA + GIK 72 _+ 5 
Control 64 ± 3 
Threonine 
AA 327 ± 40 
AA + GIK 370 _+ 17 
Control 95 + 11 
Tryptophan 
AA 84 _+ 15 
AA + GIK 88 + 7 
Control 31 _+ 4 
Tyrosine 
AA 88 -+ 12 
AA+ GIK 83_+3 
Control 55 _+ 5 
Valine 
AA 665 ± 55 
AA + GIK 669 _+ 22 
Control 271 _+ 12 
Values given as means plus or minus the standard error of the mean. 
Another matter of concern is the technique for 
RBF measurement. The clinically most commonly 
used method is based on renal clearance of para- 
aminohippurate. The technique requires urine sam- 
pling, which reduces the temporal resolution of this 
method. In contrast, the thermodilution technique 
has considerably better temporal resolution, and its 
validity in surgical conditions has been verified by 
previous work. 9 Furthermore, the extraction of 
para-aminohippurate is lower than normal in con- 
junction with cardiac operations (80% to 85% com- 
pared with the normal 90% to 95%), which reduces 
the sensitivity of the para-aminohippurate tech- 
nique. 
The RBF values after the operation were gener- 
ally higher than those before the operation. Theo- 
retically this could be the effect of changed catheter 
position. The risk of catheter displacement was 
appreciated and the position was checked after 
the operation. A more probable explanation re- 
lates to the 20% lower hemoglobin level after the 
operation, with a low oxygen content, which ne- 
cessitates a higher flow to maintain oxygen supply, 
and the lower viscosity, which reduces flow resis- 
tance. 
Effects of amino acid infusion. The amino acid 
infusion had no effect on systemic hemodynamic 
variables. This finding contrasts to that of previous 
work, which indicated that glutamate increases car- 
diac output 6 and that arginine induces vasodila- 
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tion. 12 Both glutamate and arginine were present in 
the infusion (9.9% and 4.9%, respectively, of the 
amino acid content) and arterial plasma concentra- 
tions were increased more than threefold and four- 
fold, respectively. Even so, it may be suspected that 
higher doses of these amino acids are required to 
obtain systemic hemodynamic effects. The amino 
acid infusion, however, increased RBF as well in the 
current context. RVR decreased numerically 29%. 
This was not significantly different from control 
values, which is puzzling because blood pressures 
were equal at marked ifferences in RBF. A type II 
error may be suspected. In previous work done 
during nonsurgical conditions, the fall in RVR and 
the increase in RBF after amino acid administration 
have been in the 10% to 20% range, s In the present 
study the corresponding values were more than 
twice as high. The present data cannot explain the 
amplified response. The early postoperative p riod 
is characterized by insulin resistance and renal va- 
soconstriction (relative to systemic vascular esis- 
tance), and it is worth noting that previous workers 
reported agreater response than normal in patients 
with diabetes, who have increased RVR. 13 
There is a body of evidence from animal and 
clinical nonsurgical work that indicates that amino 
acids reduce RVR and hence increase RBF. 8' 14 The 
importance of individual amino acids has been 
debated. According to some investigators arginine, 
the nitric oxide precursor, is the most potent amino 
acid, whereas other investigators conclude that 
other gluconeogenetic amino acids are equally or 
more potent, is The mechanism for amino acid- 
induced renal vasodilation is unknown. Both sys- 
temic humoral factors, such as glucagon, and intra- 
renal vasodilative agents, such as kallikrein, 
prostaglandins, dopamine, and endothelium-derived 
nitric oxide, have been proposed as being the cause 
for renal vasodilation. 1549 
The observation that the effects can be accom- 
plished also in the isolated kidney preparation implies 
a local mediator. 2° The present data indicate that 
changes in renal perfusion pressure or CI were unre- 
lated to RBF changes during amino acid infusion. 
Effects of insulin. The present data confirm that 
insulin produces ystemic vasodilation and increases 
cardiac output. In vitro work by Lucchesi, Median, 
and Kniffen 21 indicated that insulin had a positive 
inotropic effect on the canine heart. Our group 
reported dose-response data between insulin and 
hemodynamic parameters over a wide range of 
insulin dosages (up to 500 IU as a bolus) early after 
cardiac operations. 22The studies were done under 
glucose "clamp" conditions, that is, blood glucose 
was maintained euglycemic, excluding the possibility 
that the increases in cardiac output were caused by 
changes in blood glucose level. The current protocol 
was based on that experience. The previous work 
indicated that insulin is a potent vasodilating 
agent.5, 23-25 Inotropic effects are difficult o evaluate 
with the current techniques because of the low 
specificity. However, there was no difference be- 
tween groups in left ventricular stroke work index 
(according to analysis of variance) or in PCWP 
versus CI slopes (according to covariance analysis). 
These findings argue against important effects on 
contractility. Thus it appears that vasodilative effects 
are more impressive at least in patients with an 
uncomplicated course. It may be different in pa- 
tients with overt postoperative heart failure, as 
indicated by the work of Gradinac and colleagues. 4 
The combined effect of insulin and amino acids 
resulted in improved renal perfusion with decreased 
RVR and increased RBF compared with values in 
control subjects. However, the effects were not 
greater than those during amino acid infusion alone. 
Other investigators have shown renal vasodilating 
effects of insulin, 7' 23 also in the isolated kidney. 26 To 
explain the lack of effect of insulin in our study 
different alternatives may be considered. It may be 
suggested that the vasodilating effect on the kidney 
is less pronounced and concealed by the marked 
effect of the mixed amino acid infusion, or the 
profound insulin resistance in the postoperative 
period may attenuate he normal response. Alterna- 
tively, the effect may be reduced or even absent 
because of a common mediator that already has 
been activated maximally by amino acids. Further- 
more, infusion of amino acids evokes a release of 
endogenous insulin. 14 It could be speculated that 
amino acids are efficient because of endogenous 
insulin release. If so, the difference in effects on 
RVR and systemic vascular resistance would suggest 
different dose-response curves for renal and sys- 
temic vasodilation. This speculation is supported by 
the work of others, which has shown that somatosta- 
tin, which blocks insulin release, prevents amino 
acid renal vasodilation. 8 
Clinical implications and conclusions. Metabolic 
intervention is a clinical option in the treatment of 
postoperative h art failure in heart operations. The 
present data indicate that metabolic intervention 
with insulin and amino acids also enhances renal 
perfusion, at least in patients with an uncomplicated 
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postoperat ive  course. Our  f inding suggests a new 
pr inc ip le for the prevent ion  of  acute renal  fai lure in 
heart  operat ions.  Future  studies should eva luate  the 
val idity of  this suggest ion in pat ients  with a greater  
risk of  pos toperat ive  compl icat ions.  
Statistical advice was given by Anders Od6n, PhD, 
Kungfilv, Sweden. The skillful assistance of Liselott Thun- 
berg, Kerstin Andersson, PhD, and Maria St~lberg is 
gratefully acknowledged. 
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